CAS RN: 2126892-51-9
INDEX NAME NOT YET ASSIGNED
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260328
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2126892-51-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
2126892-51-9 / (4S)-4-benzyl-2-[6-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]dibenzofuran-4-yl]-4,5-dihydro-1,3-oxazole
Standard CAS: 2126892-51-9
Multi CAS: No
Basic Information
copy
CAS
2126892-51-9 copy
Multi CAS
No copy
Molecular Formula
C32H26N2O3 copy
Molecular Weight
486.600000 copy
Exact Mass
486.194343 copy
SMILES
C1[C@@H](N=C(O1)C2=CC=CC3=C2OC4=C3C=CC=C4C5=N[C@H](CO5)CC6=CC=CC=C6)CC7=CC=CC=C7 copy
InChI
InChI=1S/C32H26N2O3/c1-3-9-21(10-4-1)17-23-19-35-31(33-23)27-15-7-13-25-26-14-8-16-28(30(26)37-29(25)27)32-34-24(20-36-32)18-22-11-5-2-6-12-22/h1-16,23-24H,17-20H2/t23-,24-/m0/s1 copy
InChIKey
UMNQCKRUNPVGRM-ZEQRLZLVSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
37 copy
Aromatic heavy atom count
25 copy
Fraction Csp3
0.19 copy
Rotatable bonds
6 copy
H-bond acceptors
5 copy
Molar refractivity
146.57 copy
TPSA
56.32 copy
LogP / Solubility
WLOGP
6.36 copy
MLOGP
5.63 copy
XLogP3
6.7 copy
Consensus LogP
6.23 copy
Log S (ESOL)
-6.97 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-8.14 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-8.82 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.17 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
7 copy